TEANECK, N.J., May 04, 2017 -- Phibro Animal Health Corporation (NASDAQ:PAHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Bank of America Merrill Lynch 2017 Health Care Conference.
| When: | Thursday, May 18, 2017 | |
| Time: | 10:00 AM PDT | |
| Location: | Encore at the Wynn | |
| Las Vegas, Nevada | ||
| Presentation: | Visit http://investors.pahc.com |
The presentation will be available concurrent with the live presentation.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company reported net sales of $752 million for the fiscal year ended June 30, 2016. For further information, please visit www.pahc.com.
Our filings with the Securities and Exchange Commission are available online at www.sec.gov, www.pahc.com or on request from the company.
Contact: Richard Johnson Phibro Animal Health Corporation Chief Financial Officer +1-201-329-7300 [email protected]


Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices
CN Energy Group Inc. Stock Slides After Nasdaq Delisting Notice Over Bid Price Rule
Nvidia CEO Jensen Huang Plans China Visit Amid AI Chip Market Uncertainty
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure
FAA Says It Is Not Blocking Boeing 737 MAX 7 and MAX 10 Certification
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Microsoft Restores Microsoft 365 Services After Widespread Outage
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 



